Delivery Order SPE2DB20D3101-SPE2DB21FH5A7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through December 31, 2025. The contract serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD)...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies. The Indefinite Delivery Contract (IDC) has a ceiling value of up to $999,999,999.00 and is valid through December 31, 2025, serving as the primary vehicle for Amerisourcebergen to provide specialty, brand name, generic, and...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. Under this contract, Amerisourcebergen will deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) and other federal...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and other government agencies. The contract is a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. It serves as the primary vehicle for Amerisourcebergen to deliver specialty,...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The Indefinite Delivery Contract (IDC), valued up to $999,999,999.00 through December 31, 2025, is the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This includes specialty,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00, supports the delivery of a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and other federal healthcare programs. The contract, awarded by the Defense Logistics Agency (DLA), is a $999,999,999.00 Indefinite Delivery Contract (IDC) that runs through November 2026. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 to Amerisourcebergen Drug Corp's Corporate Office Division to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide specialty, brand name, generic, and over-the-counter medications, as well as critical care...
- This federal contract award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00 through December 31, 2025, is an Indefinite Delivery Contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FH5A7Delivery Order
This federal contract award was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials, to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Additionally, AmerisourceBergen Drug Corp holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 1/8/21 |